- ·8 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Kailera Therapeutics (NAS: KLRA) funding history
No funding rounds for Kailera Therapeutics (NAS: KLRA) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Kailera Therapeutics (NAS: KLRA) valuation
Kailera Therapeutics (NAS: KLRA) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Recent activity
In the last 90 days, Kailera Therapeutics (NAS: KLRA)'s record added 3 institutional fund marks (latest period Jul 2026).
Institutional holders and vehicles
2 SEC-registered funds reported 8 fair-value marks on Kailera Therapeutics (NAS: KLRA) between Apr 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Kailera Therapeutics (NAS: KLRA)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kailera Therapeutics (NAS: KLRA), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Kailera Therapeutics (NAS: KLRA)
- What is Kailera Therapeutics (NAS: KLRA) worth?
- Kailera Therapeutics (NAS: KLRA)'s last known valuation is $1.5B.
- How much has Kailera Therapeutics (NAS: KLRA) raised?
- Kailera Therapeutics (NAS: KLRA) has raised $1.6B in total funding across its recorded rounds.